SyncAV Post-Market Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1686 participants.
Also called NCT04100148
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,686 participants
- Sponsor
- Registry
-
NCT04100148
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Austria, Belgium, Canada, China, Finland, France, Germany, Hong Kong SAR China, India, Italy, Japan, Netherlands, Poland, Portugal, Puerto Rico, Russia, Saudi Arabia, Serbia, South Korea, Spain, Sweden, Taiwan, Thailand, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04100148. Randomized; no masking; primary purpose treatment. Start 2019-10-03 (actual); primary completion 2026-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SyncAV Post-Market Trial
- Acronym
- SyncAV
- Condition
- Congestive Heart Failure
- Intervention (Device)
- SyncAV programmed ON
- Intervention (Device)
- Fixed AV delay
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct04100148- Content hash
dff3e8535ffb7a3a5feda59a538d8c98d1624ac4b43b97995a3c2426f3135a13